Law360, New York (April 3, 2007, 12:00 AM EDT) -- U.S. antitrust regulators have sent a subpoena to Bristol-Myers Squibb Co. seeking information about a deal the drug maker made with generics rival Apotex Inc. to delay competition for its popular blood-thinner Plavix.
The request for information from the U.S. Federal Trade Commission was revealed on March 21 in Bristol-Myers Squibb’s annual regulatory filing with the U.S. Securities and Exchange Commission.
The New York-based company said in a statement that it plans to cooperate fully with the investigation. The deal at the center of the probe...
Bristol-Myers Subpoenaed Over Plavix Deal
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
